Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin B6 reduced hair loss in women with diffuse alopecia, but calcium pantothenate had no clear positive effect.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

People with Telogen Effluvium have similar zinc levels in their blood as healthy individuals.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

New understanding and treatments for hair loss are improving, but more research is needed.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Apoptosis is crucial for healthy skin and treating skin diseases.

A systematic approach is crucial for managing hair loss in women.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.